Document is current
Any future updates will be listed below
-
Authors
Shao, Changxia https://orcid.org/0000-0003-2091-7599
Ren, Yixin
Zhou, Heng
Lee, Liam C.
Chen, Cai
Dettman, Elisha J.
Cristescu, Razvan
Gozman, Alexander
Jin, Fan
Zhou, Wei
-
Funding
Funding for this research was provided by:
Merck Sharp & Dohme LLC
- License Information
-
More Information
Article History
Received: 29 August 2023
Accepted: 9 November 2023
First Online: 2 January 2024
Declarations
:
: Changxia Shao, Yixin Ren, Heng Zhou, Cai Chen, Elisha J. Dettman, Razvan Cristescu, Alexander Gozman, and Fan Jin are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and own stock in Merck & Co., Inc., Rahway, NJ, USA. Wei Zhou and Liam C. Lee are former employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. Wei Zhou is currently an employee of Eli Lilly and Company, Indianapolis, IN, USA. Liam C. Lee is currently an employee of AstraZeneca Pharmaceuticals, One MedImmune Way, Gaithersburg, MD, USA.
: The IRB approval for the Flatiron Health CGDB was obtained by Flatiron Health prior to the present study. The IRB of WCG IRB (Princeton, NJ, USA) gave ethical approval for the study protocol based on the Flatiron Health CGDB, and included a waiver of informed consent (approval ID 420180044).
